Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC
Titel:
Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC
Auteur:
Rizvi, N.A. Chul Cho, B. Reinmuth, N. Lee, K.H. Ahn, M.-J. Luft, A. van den Heuvel, M. Cobo, M. Smolin, A. Vicente, D. Moiseyenko, V. Antonia, S.J. Le Moulec, S. Robinet, G. Natale, R. Nakagawa, K. Zhao, L. Stockman, P.K. Chand, V. Peters, S.